Juliette R.
- Country
- France
- Department
- Service de pédiatrie - CRMR Maladies neuromusculaires
Research Overview
- Evaluation of Immediate Versus Delayed Azathioprine or Rituximab Therapy in Pediatric Anti-MOG Antibody-Associated Acute Demyelinating Syndromes
- Phase I/II/III Study of rAAV8-hMD1 Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy, Including Dose Determination and Long-term Safety Evaluation
Data & Insights
Has run more than one trial at 4 of 17 partner sites.
Specializations
Pediatric Neuroimmunology
The investigator specializes in treating children with demyelinating disorders, with particular expertise in myelin oligodendrocyte glycoprotein antibody-associated diseases (MOGAD).
- Autoimmune neurological conditions in children
- Pediatric demyelinating syndromes
- Neuroimmunological disorders
Their research focuses on optimizing treatment timing strategies for young patients with autoimmune neurological conditions.
Immunotherapy Research
The investigator explores therapeutic approaches using immunomodulating agents for pediatric autoimmune conditions, specifically studying the effects of azathioprine and targeted biological therapies.
- Immunosuppressive treatments
- Biological therapy applications
- Treatment timing optimization
Their work examines the impact of early intervention versus delayed treatment approaches in pediatric autoimmune disorders.
Pediatric Neurology
The investigator concentrates on acute demyelinating syndromes in children, studying disease progression and treatment outcomes in pediatric neurological conditions.
- Childhood neurological disorders
- Antibody-mediated conditions
- Relapse prevention strategies
Their research aims to establish optimal therapeutic protocols for children with autoimmune neurological diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.